Rizzo Anthony E, Yu Jennifer S
Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA,
Adv Exp Med Biol. 2015;853:85-110. doi: 10.1007/978-3-319-16537-0_6.
Radiation therapy is the most effective adjuvant treatment modality for virtually all patients with high-grade glioma. Its ability to improve patient survival has been recognized for decades. Cancer stem cells provide new insights into how tumor biology is affected by radiation and the role that this cell population can play in disease recurrence. Glioma stem cells possess a variety of intracellular mechanisms to resist and even flourish in spite of radiation, and their proliferation and maintenance appear tied to supportive stimuli from the tumor microenvironment. This chapter reviews the basis for our current use of radiation to treat high-grade gliomas, and addresses this model in the context of therapeutically resistant stem cells. We discuss the available evidence highlighting current clinical efforts to improve radiosensitivity, and newer targets worthy of further development.
放射治疗几乎是所有高级别胶质瘤患者最有效的辅助治疗方式。其改善患者生存率的能力已得到数十年的认可。癌症干细胞为肿瘤生物学如何受到辐射影响以及该细胞群体在疾病复发中所起的作用提供了新的见解。胶质瘤干细胞拥有多种细胞内机制,即使在辐射环境下也能抵抗甚至增殖,它们的增殖和维持似乎与肿瘤微环境的支持性刺激有关。本章回顾了我们目前使用放射治疗高级别胶质瘤的依据,并在治疗抗性干细胞的背景下探讨了这一模式。我们讨论了现有证据,强调了当前提高放射敏感性的临床努力,以及值得进一步开发的新靶点。